![](/img/cover-not-exists.png)
PDB15 A COST-EFFECTIVENESS ANALYSIS OF SWITCHING TYPE-2 DIABETES PATIENTS FROM IMMEDIATE-RELEASE METFORMIN (GLUCOPHAGE®) TO A NEW EXTENDEDRELEASE FORMULATION OF METFORMIN (GLUCOPHAGE®XR)
C Renaudin, S Roze, WJ Valentine, AJ PalmerVolume:
7
Year:
2004
Language:
english
DOI:
10.1016/s1098-3015(10)65958-x
File:
PDF, 65 KB
english, 2004